Literature DB >> 19012746

Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C.

Odete A B da Cruz e Silva1, Sandra Rebelo, Sandra I Vieira, Sam Gandy, Edgar F da Cruz e Silva, Paul Greengard.   

Abstract

Alzheimer's amyloid precursor protein (APP) sorting and processing are modulated through signal transduction mechanisms regulated by protein phosphorylation. Notably, protein kinase C (PKC) appears to be an important component in signaling pathways that control APP metabolism. PKCs exist in at least 11 conventional and unconventional isoforms, and PKCalpha and PKCepsilon isoforms have been specifically implicated in controlling the generation of soluble APP and amyloid-beta (Abeta) fragments of APP, although identification of the PKC substrate phospho-state-sensitive effector proteins remains challenging. In the current study, we present evidence that chronic application of phorbol esters to cultured cells in serum-free medium is associated with several phenomena, namely: (i) PKCalpha down-regulation; (ii) PKCepsilon up-regulation; (iii) accumulation of APP and/or APP carboxyl-terminal fragments in the trans Golgi network; (iv) disappearance of fluorescence from cytoplasmic vesicles bearing a green fluorescent protein tagged form of APP; (v) insensitivity of soluble APP release following acute additional phorbol application; and (vi) elevated cellular APP mRNA levels and holoprotein, and secreted Abeta. These data indicate that, unlike acute phorbol ester application, which is accompanied by lowered Abeta generation, chronic phorbol ester treatment causes differential regulation of PKC isozymes and increased Abeta generation. These data have implications for the design of amyloid-lowering strategies based on modulating PKC activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012746      PMCID: PMC2911029          DOI: 10.1111/j.1471-4159.2008.05770.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  44 in total

1.  Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo.

Authors:  S Rossner; K Mendla; R Schliebs; V Bigl
Journal:  Eur J Neurosci       Date:  2001-04       Impact factor: 3.386

2.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

Authors:  T E Golde; S Estus; L H Younkin; D J Selkoe; S G Younkin
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

3.  Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells.

Authors:  D Paola; C Domenicotti; M Nitti; A Vitali; R Borghi; D Cottalasso; D Zaccheo; P Odetti; P Strocchi; U M Marinari; M Tabaton; M A Pronzato
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

4.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

Authors:  J D Buxbaum; M Oishi; H I Chen; R Pinkas-Kramarski; E A Jaffe; S E Gandy; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

5.  Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.

Authors:  A Y Hung; C Haass; R M Nitsch; W Q Qiu; M Citron; R J Wurtman; J H Growdon; D J Selkoe
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein.

Authors:  Cristina Lanni; Michela Mazzucchelli; Emanuela Porrello; Stefano Govoni; Marco Racchi
Journal:  Eur J Biochem       Date:  2004-07

7.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

8.  Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

Authors:  P Seubert; T Oltersdorf; M G Lee; R Barbour; C Blomquist; D L Davis; K Bryant; L C Fritz; D Galasko; L J Thal
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

9.  Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding.

Authors:  Annat F Ikin; Mirsada Causevic; Steve Pedrini; Lyndsey S Benson; Joseph D Buxbaum; Toshiharu Suzuki; Simon Lovestone; Shigeki Higashiyama; Tomas Mustelin; Robert D Burgoyne; Sam Gandy
Journal:  Mol Neurodegener       Date:  2007-12-09       Impact factor: 14.195

10.  APP processing is regulated by cytoplasmic phosphorylation.

Authors:  Ming-Sum Lee; Shih-Chu Kao; Cynthia A Lemere; Weiming Xia; Huang-Chun Tseng; Ying Zhou; Rachael Neve; Michael K Ahlijanian; Li-Huei Tsai
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  17 in total

1.  Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Keely M Murphy; Liping Meng; Janitza Montalvo-Ortiz; Ziling Zeng; Benedict J Kolber; Shanshan Zhang; Louis J Muglia; John G Csernansky
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.

Authors:  Hongxin Dong; Shirlene Wang; Ziling Zeng; Fei Li; Janitza Montalvo-Ortiz; Christopher Tucker; Shahzad Akhtar; Jingshan Shi; Herbert Y Meltzer; Kenner C Rice; John G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  2014-05-27       Impact factor: 4.530

3.  Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ1-40/42 and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer's disease.

Authors:  Mini P Sajan; Barbara C Hansen; Margaret G Higgs; C Ron Kahn; Ursula Braun; Michael Leitges; Collin R Park; David M Diamond; Robert V Farese
Journal:  Neurobiol Aging       Date:  2017-09-15       Impact factor: 4.673

Review 4.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

Authors:  Timothy J Revett; Glen B Baker; Jack Jhamandas; Satyabrata Kar
Journal:  J Psychiatry Neurosci       Date:  2013-01       Impact factor: 6.186

Review 5.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

6.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

7.  Alphabeta hinders nuclear targeting of AICD and Fe65 in primary neuronal cultures.

Authors:  A G Henriques; S I Vieira; E F da Cruz e Silva; O A B da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2009-04-02       Impact factor: 3.444

8.  S655 phosphorylation enhances APP secretory traffic.

Authors:  Sandra Isabel Vieira; Sandra Rebelo; Sara Catarina Domingues; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Mol Cell Biochem       Date:  2009-04-21       Impact factor: 3.396

9.  Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.

Authors:  Thomas J Nelson; Changhai Cui; Yuan Luo; Daniel L Alkon
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

10.  APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis.

Authors:  Odete A B da Cruz E Silva; Sandra I Vieira; Joana F da Rocha; Luísa Bastos; Sara C Domingues; Ana R Bento; Uwe Konietzko
Journal:  Mol Neurobiol       Date:  2020-10-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.